GlassScriptPhysician profile
Khadeer A Khan
NPI 1588964456
$2,077.76
in general payments reported to CMS, 2019-2025
11 companies · $491 in 2025
The $491 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $418 · 2022: $943 · 2023: $100 · 2024: $126 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $482.25 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $469.52 | 2021-2025 | Invega Sustenna, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $376.58 | 2021-2025 | Caplyta |
| Alkermes, INC. | $255.91 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $188.14 | 2021-2023 | Rexulti |
| Lundbeck LLC | $158.25 | 2021-2025 | Abilify Maintena, Rexulti |
| Sunovion Pharmaceuticals INC. | $46.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $28.40 | 2025 | |
| Lilly USA, LLC | $27.99 | 2023 | Mounjaro, Trulicity |
| Boston Scientific Corporation | $23.92 | 2025 | Varithena Administration Pack |
| Teva Pharmaceuticals USA, INC. | $20.57 | 2025 | Uzedy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khadeer Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.